Consio | $3,300,000 | (Jan 27, 2026)
Orbital(US) | $60,000,000 | (Jan 27, 2026)
Inferact | $150,000,000 | (Jan 27, 2026)
Certified by Founder
Lodge
Epoch Biodesign
start up
United Kingdom
- London
- 22/06/2022
- Seed
- $11,000,000
Epoch is the Total BioDesign company developing natural solutions to unnatural problems. We are designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals.
- Industry Biotechnology
- Website https://www.epochbiodesign.com/
- LinkedIn https://www.linkedin.com/company/epochbiodesign/
Visitt | $22,000,000 | (Jan 27, 2026)
Cashmere(US) | $5,000,000 | (Jan 27, 2026)
Barnwell Bio | $6,000,000 | (Jan 27, 2026)
Mine(US) | $14,000,000 | (Jan 27, 2026)
Lucend | $3,300,000 | (Jan 27, 2026)
Standard Nuclear | $140,000,000 | (Jan 27, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)